TALPHERA, INC. — Director's Dealing 2019

Mar 12, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
CIK: 0001427925
Period of Report: 2019-03-12

Reporting Person: EDWARDS MARK G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-12	Common Stock	P	19000	$2.9942	Acquired	200000	Direct

Footnotes

F1: The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $2.98 to $3.00 on March 12, 2019. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price.